Role of integrin-linked kinase in multi-drug resistance of human gastric carcinoma SGC7901/DDP cells

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5619-5625

  Song, Wei ^a   Jiang, Rui ^a   Zhao, Chun Ming ^b  

^a Department of Oncology ^*  (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Gastric carcinoma; Integrin linked kinase; Multidrug resistance

Indexed keywords

EID: 84874047818     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5619     Document Type: Article

References (21)

1. Berti C, Bartesaghi L, Ghidinelli M, et al (2011). Non-redundant function of dystroglycan and β1 integrins in radial sorting of axons. Development, 8, 4025-37.
2. Brenner H, Rothenbacher D, Arndt V (2009). Epidemiology of stomach cancer. Cancer Epidemiology: Methods in Molecular Biology, 472, 467-77.
3. Chen DQ, Yao DX, Zhao HY, et al (2012). DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis. Asian Pac J Cancer Prev,6, 2791-4.
4. Engelman JA (2009). Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer, 8, 550-62.
5. Gao J, Zhu J, Li HY, et al (2011). Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells. Int J Biochem Cell Biol, 9, 1294-304.
6. Karen-Ng LP, Marhazlinda J, Rahman ZA, et al (2011). Combined effects of isothiocyanate intake, glutathione S-transferase polymorphisms and risk habits for age of oral squamous cell carcinoma development. Asian Pac J Cancer Prev, 5, 1161-6.
7. Keppler D (2011). Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy. Handb Exp Pharmacol, 201, 299-323.
8. Kim MK, Cho KJ, Kwon GY, et al (2008). ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer. Eur J Cancer, 1, 54-60.
9. Martin LP, Hamilton TC, Schilder RJ (2008). Platinum resistance: the role of DNA repair pathways. Clin Cancer Res, 5, 1291-5.
10. Li K, Lu Y, Liang J, et al (2009). RhoE enhances multidrug resistance of gastric cancer cells by suppressing Bax. Biochem Biophys Res Commun, 2, 212-6.
11. Li W, Melton DW (2012). Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance. Oncogene, 19, 2412-22.
12. Maeda O, Shibata K, Hosono S, et al (2012). Spectrin aII and βII tetramers contribute to platinum anticancer drug resistance in ovarian serous adenocarcinoma. Int J Cancer, 1, 113-21.
13. Pereira JA, Benninger Y, Baumann R, et al (2009). Integrinlinked kinase is required for radial sorting of axons and Schwann cell remyelination in the peripheral nervous system. J Cell Biol, 1, 147-61.
14. Piacentini P, Durante E, Trolese A, et al (2012).Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experience. Gastric Cancer, 1, 106-10.
15. Shah MA, Kelsen DP (2010). Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. J Natl Compr Canc Netw, 4, 437-47.
16. Su JL, Chiou J, Tang CH, et al (2010). CYR61 regulates BMP- 2-dependent osteoblast differentiation through the {alpha} v{beta}3 integrin/integrin-linked kinase/ERK pathway. J Biol Chem, 41, 31325-36.
17. Vilmar A, Sørensen JB (2009). Excision repair crosscomplementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature. Lung Cancer, 2, 131-9.
18. Wagner EF, Nebreda AR (2009). Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer, 8, 537-49.
19. Wong RP, Ng P, Dedhar S, et al (2007). The role of integrinlinked kinase in melanoma cell migration, invasion, and tumor growth. Mol Cancer Ther, 6, 1692-700.
20. Zhang Y, Qu X, Jing W, et al (2009).GSTP1 determines cisplatinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling. Anticancer Drugs, 3, 208-14.
21. Zhao P, Dai M, Chen W, Li N (2010). Cancer trends in China. Jpn J Clin Oncol, 4, 281-5.